Search
Powered By HealthLine
Special Offers
TV Specials
 Learn about an Effective Alzheimer's Medication
 Bipolar Education Health Center
 Osteoarthritis of the Knee Solution Center
 Heartburn Education Center
 Breast Cancer Health Center
 Crohn's Disease Health Center
 Schizophrenia Education Center
Top Features
 Depression
 Schizophrenia
 Breast Cancer
 Bipolar
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Multiple Sclerosis Drug Combats Vision Loss


Related Encyclopedia
 border=
Acidophilus
Acoustic Neurinoma
Antioxidants
Bell's Palsy
More...

Related Healthscout Videos
 border=
Brain Surgery with Water?
Breakthrough Coma Reversal With Glue
Helping Blind Kids See
MS Discovery
More...

Related Animations
 border=
LASIK
More...

Related Drug Information
 border=
Adderal XR
Concerta
Coumadin
Depakote
More...

Related News Articles
 border=
Health Tip: Taking Folic Acid
Cancer Drug Trials Often Halted Early
When a Mind Begins to Disappear: A Young Family's Journey to the Dark Side
Health Tip: Weight Gain During Pregnancy
More...


Page:  << Prev | 1 | 2

One expert thinks that despite the vision benefit, Tysabri should be reserved for patients with aggressive MS or those who failed other medications.

"This study confirms the benefits of this particular MS drug in relapsing MS patients," said Dr. Anne H. Cross, a professor of neurology at Washington University School of Medicine, in St. Louis. "In addition, it validates the use of a new vision test which is relevant to MS."

But the benefit to vision doesn't negate the risks associated with the drug, Cross said. "I don't think I will change my prescribing habits based upon this paper," she said. "I will probably continue to use it in the same type of patients I have been using it in in the past."

Text Continues Below



However, Nicholas LaRocca, the director of health care delivery and policy research at the National Multiple Sclerosis Society, said the new study provides additional insight into the benefits of the drug and may influence the decision whether to start using it or not.

"For patients who are on natalizumab or considering natalizumab, this gives them another piece of information to consider as they are trying to make their decision," he said.

According to the U.S. National Institutes of Health, multiple sclerosis is an unpredictable disease of the central nervous system that can range from relatively benign to somewhat disabling to devastating, as communication between the brain and other parts of the body is disrupted. Many researchers believe MS to be an autoimmune disease -- one in which the body, through its immune system, launches a defensive attack against its own tissues. In the case of MS, it is the nerve-insulating myelin that comes under assault.

More information

The National Multiple Sclerosis Society can tell you more about multiple sclerosis.

Page:  << Prev | 1 | 2

Copyright © 2007 ScoutNews, LLC. All rights reserved.
Last updated 4/17/2007

Related Links
 border=
From Healthscout's partner site on chronic pain, ChronicPainConnection.com
Find ways to get chronic pain relief!
Find a right treatment for your chronic pain
Join our community - your chronic pain support group.





New Features

New ADHD Site!

SOURCES: Laura J. Balcer, M.D., associate professor of neurology, University of Pennsylvania School of Medicine, Philadelphia; Nicholas LaRocca, Ph.D., director of health care delivery and policy research, National Multiple Sclerosis Society, New York City; Anne H. Cross, M.D., professor, neurology, Washington University School of Medicine, St. Louis; April 17, 2007, Neurology


About The HealthScout Network Contact Us
Copyright © 2001-2009. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service   Site Map